Total Payments
$11,069
2024 Payments
$1,490
Companies
41
Transactions
311
Medicare Patients
7,378
Medicare Billing
$906,634
Payment Breakdown by Category
Food & Beverage$9,993 (90.3%)
Travel$969.80 (8.8%)
Education$105.97 (1.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,993 | 305 | 90.3% |
| Travel and Lodging | $969.80 | 4 | 8.8% |
| Education | $105.97 | 2 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $1,795 | 31 | $0 (2024) |
| Medtronic Vascular, Inc. | $1,377 | 18 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $1,005 | 31 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $773.75 | 29 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $691.17 | 33 | $0 (2024) |
| Boston Scientific Corporation | $551.55 | 18 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $476.56 | 16 | $0 (2024) |
| Biosense Webster, Inc. | $425.33 | 5 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $424.97 | 15 | $0 (2024) |
| ABIOMED | $393.01 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,490 | 58 | Abbott Laboratories ($176.60) |
| 2023 | $1,805 | 52 | Biosense Webster, Inc. ($425.33) |
| 2022 | $987.25 | 35 | Medtronic, Inc. ($215.49) |
| 2021 | $331.48 | 15 | Medtronic, Inc. ($57.02) |
| 2020 | $298.34 | 10 | Novartis Pharmaceuticals Corporation ($108.71) |
| 2019 | $2,208 | 50 | Medtronic Vascular, Inc. ($1,028) |
| 2018 | $1,290 | 32 | Abbott Laboratories ($395.23) |
| 2017 | $2,660 | 59 | Abbott Laboratories ($796.52) |
All Payment Transactions
311 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $29.73 | General |
| Category: Heart Failure and Hypertension | ||||||
| 12/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Cardio-renal | ||||||
| 12/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Oncology | ||||||
| 11/19/2024 | AGEPHA Pharma FZ LLC | LODOCO (Drug) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Cardiovascular Diseases | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.48 | General |
| Category: Cardiovascular | ||||||
| 11/08/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Neuromodulation | ||||||
| 11/07/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $28.15 | General |
| Category: Cardiology | ||||||
| 11/06/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $104.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: DIABETES | ||||||
| 10/30/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $20.40 | General |
| 10/08/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/25/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $15.25 | General |
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/03/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $39.11 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/27/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/13/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $25.95 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/06/2024 | CORDIS US CORP. | MYNX CONTROL (Device) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Cardiovascular | ||||||
| 08/05/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/01/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $22.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/30/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $14.37 | General |
| Category: Heart Failure and Hypertension | ||||||
| 07/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Cardiology | ||||||
| 07/11/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $25.60 | General |
| Category: Heart Failure and Hypertension | ||||||
| 07/09/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 2,690 | 3,976 | $562,179 | $263,612 |
| 2022 | 32 | 2,317 | 3,624 | $547,618 | $265,386 |
| 2021 | 19 | 1,446 | 2,311 | $333,552 | $209,183 |
| 2020 | 13 | 925 | 1,526 | $268,509 | $168,453 |
Total Patients
7,378
Total Services
11,437
Medicare Billing
$906,634
Procedure Codes
101
All Medicare Procedures & Services
101 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 218 | 262 | $56,500 | $37,878 | 67.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 182 | 343 | $51,450 | $35,166 | 68.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 123 | 255 | $38,250 | $25,344 | 66.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 66 | 66 | $56,100 | $23,629 | 42.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 117 | 126 | $44,100 | $19,938 | 45.2% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 66 | 132 | $66,000 | $11,712 | 17.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 108 | 160 | $12,363 | $9,893 | 80.0% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 65 | 65 | $19,500 | $9,857 | 50.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 52 | 59 | $10,325 | $7,781 | 75.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 79 | 104 | $13,000 | $7,492 | 57.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 800 | 1,022 | $10,260 | $6,745 | 65.7% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 97 | 135 | $10,125 | $5,962 | 58.9% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 22 | 23 | $24,807 | $5,472 | 22.1% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 25 | 175 | $10,500 | $5,304 | 50.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $11,100 | $4,788 | 43.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 30 | 30 | $12,000 | $4,630 | 38.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 73 | 75 | $12,930 | $4,041 | 31.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 18 | 19 | $4,630 | $3,704 | 80.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 33 | 33 | $4,811 | $3,604 | 74.9% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 67 | 68 | $10,200 | $3,443 | 33.8% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 26 | 104 | $10,400 | $3,438 | 33.1% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 20 | 145 | $8,700 | $3,112 | 35.8% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 33 | 35 | $9,038 | $3,022 | 33.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 20 | 21 | $3,608 | $2,727 | 75.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 12 | 15 | $4,373 | $2,705 | 61.9% |
About Dr. Sameer Verma, MD
Dr. Sameer Verma, MD is a Cardiovascular Disease healthcare provider based in Boynton Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2009. The National Provider Identifier (NPI) number assigned to this provider is 1932334935.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sameer Verma, MD has received a total of $11,069 in payments from pharmaceutical and medical device companies, with $1,490 received in 2024. These payments were reported across 311 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($9,993).
As a Medicare-enrolled provider, Verma has provided services to 7,378 Medicare beneficiaries, totaling 11,437 services with total Medicare billing of $906,634. Data is available for 4 years (2020–2023), covering 101 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Boynton Beach, FL
- Active Since 05/19/2009
- Last Updated 09/12/2016
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1932334935
Products in Payments
- ClosureFast (Device) $1,107
- XARELTO (Drug) $1,005
- ENTRESTO (Drug) $609.24
- BRILINTA (Drug) $450.39
- Xience V coronary stent system (Device) $446.02
- ELIQUIS (Drug) $437.11
- CARTO 3 (Device) $425.33
- Impella (Device) $393.01
- KENGREAL (Drug) $327.17
- WATCHMAN (Device) $324.39
- Mitra Clip system (Device) $322.60
- JARDIANCE (Drug) $266.09
- Repatha (Biological) $226.16
- Barostim Neo System (Device) $210.47
- LifeVest (Device) $180.73
- AVEIR (Device) $174.14
- MOSAIC (Device) $168.93
- FARXIGA (Drug) $166.61
- LEQVIO (Drug) $164.51
- Xience Alpine cornary stent system (Device) $160.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Boynton Beach
Roberto Von Sohsten, Md, MD
Cardiovascular Disease — Payments: $16,288
Cardiovascular Disease $16,288
Mr. Rizwan Karatela, M.d, M.D
Cardiovascular Disease — Payments: $14,149
Cardiovascular Disease $14,149
Sameh Youssef, Md Facc, MD FACC
Cardiovascular Disease — Payments: $12,377
Cardiovascular Disease $12,377
Dr. Rachel Eidelman, M.d, M.D
Cardiovascular Disease — Payments: $11,731
Cardiovascular Disease $11,731
George Daniel, Md, MD
Cardiovascular Disease — Payments: $11,355
Cardiovascular Disease $11,355
Dr. Christina Michael, Md, MD
Cardiovascular Disease — Payments: $10,945
Cardiovascular Disease $10,945